Avid golfer Robert Knorr found he was no longer able to hit the links last year, due to neuropathy in his legs and feet.

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

Saluda Medical announced that it appointed Barry Regan as its new president and CEO, effective July 14, 2025. Regan most ...

Engineers from USC and UCLA have developed a wireless, AI-driven spinal implant that delivers smart, real-time pain relief.

According to a new comprehensive report from The Insight Partners, the electrotherapy systems market is witnessing ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

The global Spinal Cord Stimulator Market is estimated to be valued at USD 3,011.0 million in 2025 and is projected to reach USD 5,291.4 million by 2035, registering a compound annual growth rate (CAGR ...

Abbott, a medical devices and health care company, won gold for its Eterna spinal cord stimulation system within the Chronic Conditions Treatment Solutions category at the 2025 Edison Awards, an ...

ABBOTT PARK, Ill., Jan. 30, 2025 – Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people ...

MONTRÉAL, March 19, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the company's Eterna™ SCS system – the smallest implantable, rechargeable spinal cord stimulator (SCS) for the ...

But in recent years, labs have made major strides in innovative techniques that can be applied long after the initial damage to the spinal cord, including using electrical currents to re-awaken ...

On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not ...